NurExone Biologic's total assets for Q3 2024 were $3.61M, an increase of 9.78% from the previous quarter. TSE:NRX total liabilities were $466.00K for the fiscal quarter, a -35.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.